Polymyalgia rheumatica and giant cell arteritis
- 12 August 1995
- Vol. 311 (7002) , 455
- https://doi.org/10.1136/bmj.311.7002.455a
Abstract
EDITOR,--We disagree with Gillian Pountain and Brian Hazleman's assertion that 20-40 mg of prednisolone is adequate initial treatment for patients with giant cell arteritis who have no ocular symptoms. As the authors state, appreciable visual loss occurs in 30-50% of patients with untreated giant cell arteritis. Anterior ischaemic optic neuropathy accounts for 90% of these cases, the remainder being secondary to retinal artery occlusions or, rarely, an ocular ischaemic syndrome. Although prodromal symptoms such as transient obscuration of vision …Keywords
This publication has 4 references indexed in Scilit:
- ABC of Rheumatology: POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITISBMJ, 1995
- Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.Annals of the Rheumatic Diseases, 1989
- Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.Annals of the Rheumatic Diseases, 1989
- Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).Annals of the Rheumatic Diseases, 1988